Antioxidantul polifenolic EGCG

27 Ceai Verde cu polifenoli de catechine EGCG - Galatul de epigalocatechina extr. stand. 50% cu uz medicinal si aplicatii la cancer

28 EGCG - Galatul de epigalocatechina extr. stand. 50% cu efect anticarcinogenic

29 Ceai Verde cu polifenoli de catechine EGCG - Galatul de epigalocatechina extr. stand. 50% previne cancerul

30 Ceai Verde cu polifenoli de catechine EGCG - Galatul de epigalocatechina extr. stand. 50% inhiba cresterea tumorala

32 Extractul EGCG - Galatul de epigalocatechina extr. stand. 50% inhiba celulele oncogene

33 Ceai Verde antioxidant cu catechine EGCG - Galatul de epigalocatechina extr. stand. 50% un anticancer inhiba carcinogeneza la glanda mamara

36 Extractul EGCG - Galatul de epigalocatechina extr. stand. 50% inhiba si actioneaza regresia de enzima ornitin decarboxilaza la celulele de cancer de prostata (PC-3) si cancerul mamar

37 Ceai Verde cu polifenoli de catechine EGCG - Galatul de epigalocatechina extr. stand. 50% inhiba enzima ornitin decarboxilaza la celulele de cancer de prostata (PC-3)

38 Ceai Verde cu polifenoli de catechine EGCG - Galatul de epigalocatechina extr. stand. 50% reduce enzima 5-alfa reductaza este un agent citostatic natural, inhiba proliferarea celulelor canceroase de prostata

42 EGCG - Galatul de epigalocatechina extr. stand. 50% sinergic cu Sulindac sau Tamoxifen activitatea de preventie la cancer de plamin pe linia celulara PC-9

43 Ceai Verde cu polifenoli de catechine EGCG - Galatul de epigalocatechina extr. stand. 50% un imunomodulator si de inhibare la cancer de plamin

45 Ceai Verde cu polifenoli de catechine EGCG - Galatul de epigalocatechina extr. stand. 50% inhiba carcinogeneza gastrointestinala

46 Ceai Verde cu polifenoli de catechine EGCG - Galatul de epigalocatechina extr. stand. 50% un anticancer si antiinflamator selectiv COX-2, inhibitor in cresterea celulelor de cancer la prostata in vitro si vivo

47 Ceai Verde cu polifenoli de catechine EGCG - Galatul de epigalocatechina extr. stand. 50% un antiinflamator selectiv COX-2, fara sa afecteze COX-1 in expresia umana a celulelor de cancer la prostata

61 Consumul de Ceai Verde cu efect pozitiv, corelat cu reducerea mortalitatii indusa de bolile cardiovasculare, cancer si alte cazuri, studiul Ohsaki

27 Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Drug Discovery Program, Biosciences Division, SRI International, Menlo Park, CA 94025, USA. Life Sci. 2006 Mar 27;78(18):2073-80. Epub 2006 Jan 30.
28 Fujiki H, Yoshizawa S, Horiuchi T, Suganuma M, Yatsunami J, Nishiwaki S, Okabe S, Nishiwaki-Matsushima R, Okuda T, Sugimura T. Anticarcinogenic effects of (-)-epigallocatechin gallate. Cancer Prevention Division, National Cancer Center Research Institute, Tokyo, Japan. Prev Med. 1992 Jul;21(4):503-9.
29 Imai K, Suga K, Nagachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med. 1997;26(6):769-775.
- Mukhtar H., Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr., 71: 1698S-702S, 2000.
- Cao Y., Cao R. Angiogenesis inhibited by drinking tea. Nature (Lond.), 398: 381 1999.
- Brown MD. Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Alt Med Rev. 1999;4(5):360-370.
- Sazuka M, et al. Inhibitory effects of green tea infusion on in vitro invasion and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett 1995;98:27-31.
30 Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer letters 1998;133:19-26
- Fujiki H, Suganuma M, Okabe S, et al. Cancer inhibition by green tea. Mutation Research. 1998;307-310.
- Gao Yt, McLaughlin JK, Blot WJ Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst. 1994 Jun 1;86(11):855-8.
- Hirose M. Inhibition of mammary gland carcinogenesis by green tea catechins. Cancer Lett 1994;83:149-156.
- Inoue M, Tajima K, Mizutani M, et al. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett. 2001;167(2):175-182.
- Kaegi E. Unconventional therapies for cancer: 2. Green tea. [Review]. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ. 1998;158(8):1033-1035.
- Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 1998;89(3):254-261.
- Pianetti S, Guo S, Kavanagh KT, Sonenshein GE. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 2002;62(3):652-655.
- Setiawan VW, Zhang ZF, Yu GP, et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer. 2001;92(4):600-604.
- Sano T, Sasako M. Green tea and gastric cancer. N Engl J Med. 2001;344(9):675-676.
- Tsubono Y, Nishino Y, Komatsu S, et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med. 2001;344(9):632-636.
- Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH. Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control. 1995;6(6):532-538.
- Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer Lett. 1998;133(1):19–26.
- Ji B-T, Chow W-H, Hsing AW, et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer. 1997;70:255-258.
- Fujiki H, Suganuma M, Okabe S, et al. Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med. 1999;220(4):225–228.
- Ahmad N, Mukhtar H. Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev. 1999; 57:78-83.
- Ahmad N, et al. Green tea constituent epigallocathechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. H Natl Cancer Inst 1997;89:1881-86.
- Wang Z, et al. Antimutagenic activity of green tea polyphenols. Mutation Research. 1989;223:273-285.
- Jankun J, et al. Why drinking green tea could prevent cancer. Nature 1997;387:561
- Taniguchi S, et al. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cells lines. Cancer Lett 1992;65:51-4.
-Kaegi E, on behalf of the Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. Unconventional therapies for cancer: 2. Green tea. Canadian Medical Association 1998;158:1033-1035.
32 Hu G, Han C, Chen J.Inhibition of oncogene expression by green tea and (-)-epigallocatechin gallate in mice. Institute of Nutrition and Food Hygiene, Chinese Academy of Preventive Medicine, Beijing, China. Nutr Cancer. 1995;24(2):203-9.
33 Hirose M, Hoshiya T, Akagi K, Futakuchi M, Ito N. Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[alpha]anthracene. First Department of Pathology, Nagoya City University, Medical School, Japan. Cancer Lett. 1994 Aug 15;83(1-2):149-56.
- Tanaka H, Hirose M, Kawabe M, Sano M, Takesada Y, Hagiwara A, Shirai T. Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats. First Department of Pathology, Nagoya City University Medical School, Mizuho-ku, Japan. Cancer Lett. 1997 Jun 3;116(1):47-52.
36 Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 1995;96:239-243.
- Carlin BI, Pretlow TG, Pretlow TP, et al. Green tea polyphenols inhibit growth of PC xenograft cwr-22 and decrease ornithine decarboxylase activity: implications for PC chemoprevention. J Urol 155: 510A, 1996.
37 Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Department of Dermatology, Case Western Reserve University, Cleveland, Ohio 44106, USA. Cancer Res. 1999 May 1;59(9):2115-20.
38 Liao S, Hipakka, RA. Selective inhibition of steroid 5-alfa-reductase [5AR] by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochemical and Biophysical Research Communications; 214(3), 833-838,1995).
- Gupta S, Ahmad N, Mukhtar H. Prostate cancer chemoprevention by green tea. Semin Urol Oncol. 1999; 17:70-76.
- Suganuma M, Okabe S, Sueoka N, et al. Green tea and cancer chemoprevention. Mutation Res. 1999; 428:339-344.
- Suganuma M, Okabe S, Kai Y, et al. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Research 1999; 59: 44-47.
42 Suganuma M, Okabe S, Kai Y, et al. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Research 1999; 59: 44-47.
43 Zhu M, Gong Y, Ge G. Effects of green tea on growth inhibition and immune regulation of Lewis lung cancer in mice Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing. Zhonghua Yu Fang Yi Xue Za Zhi. 1997 Nov;31(6):325-9.
45 Yamane T, Nakatani H, Kikuoka N, Matsumoto H, Iwata Y, Kitao Y, Oya K, Takahashi T. Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. First Department of Surgery, Kyoto Prefectural University of Medicine, Japan. Cancer. 1996 Apr 15;77(8 Suppl):1662-7.
46 Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA. Clin Cancer Res. 2007 Mar 1;13(5):1611-9.
47 Hussain T, Gupta S, Adhami VM, Mukhtar H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. University of Wisconsin, Department of Dermatology, 1300 University Ave., Madison, WI 53706, USA. Int J Cancer. 2005 Feb 10;113(4):660-9.
61 Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. JAMA. 2006 Sep 13;296(10):1255-65.

Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.